- Activity pressure is positive on the latest completed week.
1666
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Tong Ren Tang Technologies Co. Ltd. · Healthcare · Drug Manufacturers - General
Latest close
3.37 HKD
-4.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -11.2% below the Trend Line and sits at 11.3% of its 52-week range. The latest completed week returned -4.4%, after a 2.9% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
25
out of 100
Latest Close
3.37 HKD
7 Aug 2026
1W Return
-4.4%
latest completed week
4W Return
2.9%
short-term follow-through
12W Return
-5.5%
quarterly tape
Trend Breadth
11.5%
6 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.90% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-4.4%
Latest completed week; four-week move 2.9%.
Indicator stack
6/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.90%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -11.2% below the Trend Line and sits at 11.3% of its 52-week range. The latest completed week returned -4.4%, after a 2.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.01
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.9% over four weeks, -5.5% over 12 weeks, and -34.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year6
Trend breadth11.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.56Latest activity-pressure read.
Pressure change142.7%Four-week change in activity pressure.
Leadership-19.76Latest relative-leadership reading.
RS change1.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.3%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2618 weeks finished lower.
Best week+7.0%Week of 17 Jul.
Worst week-4.9%Week of 26 Jun.
Latest week-4.4%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains5
Flat weeks1
Modest losses13
Sharp losses5
Recent vol3.8%13-week weekly-return volatility.
Base vol2.7%52-week weekly-return volatility.
Up/down split16/35Count of positive and negative weeks in the 52-week window.
Average skew2.3% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank- / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Drug Manufacturers - General
4-week rank5 / 7
Group average28.5%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD28.6%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 43.90%Next-week expectancy is negative with a 43.90% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3.37 HKD | -4.4% | 3.79 HKD | 4.80 HKD | 0.56 | -19.76 | 2.6M | Off |
| 31 Jul 2026 | 3.52 HKD | 2.3% | 3.83 HKD | 4.82 HKD | 0.26 | -17.50 | 2.8M | Off |
| 24 Jul 2026 | 3.44 HKD | -1.7% | 3.86 HKD | 4.84 HKD | -0.19 | -17.14 | 2.5M | Off |
| 17 Jul 2026 | 3.50 HKD | 7.0% | 3.89 HKD | 4.86 HKD | -0.75 | -15.04 | 4.9M | Off |
| 10 Jul 2026 | 3.27 HKD | -2.1% | 3.92 HKD | 4.87 HKD | -1.31 | -20.00 | 3.5M | Off |
| 3 Jul 2026 | 3.34 HKD | 6.7% | 3.97 HKD | 4.89 HKD | -1.58 | -16.12 | 588.0K | Off |
| 26 Jun 2026 | 3.13 HKD | -4.9% | 4.01 HKD | 4.91 HKD | -1.77 | -19.61 | 1.4M | Off |
| 19 Jun 2026 | 3.29 HKD | -2.4% | 4.07 HKD | 4.94 HKD | -1.69 | -20.52 | 4.3M | Off |
| 12 Jun 2026 | 3.37 HKD | 0.6% | 4.11 HKD | 4.96 HKD | -1.67 | -21.72 | 1.0M | Off |
| 5 Jun 2026 | 3.35 HKD | 1.1% | 4.16 HKD | 4.98 HKD | -1.61 | -23.49 | 870.0K | Off |
| 29 May 2026 | 3.32 HKD | -4.1% | 4.21 HKD | 5.00 HKD | -1.51 | -25.61 | 16.3M | Off |
| 22 May 2026 | 3.46 HKD | -2.9% | 4.25 HKD | 5.02 HKD | -1.51 | -24.37 | 5.3M | Off |
| 15 May 2026 | 3.56 HKD | -2.3% | 4.29 HKD | 5.04 HKD | -1.55 | -23.76 | 6.3M | Off |
| 8 May 2026 | 3.65 HKD | 0.8% | 4.33 HKD | 5.06 HKD | -1.55 | -23.82 | 4.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.